Erratum: The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation (Science Translational Medicine (2018) 10:471 (eaaw2634) DOI:10.1126/scitranslmed.3009443);The HMGB1-RAGE axis mediates traumaticbrain injury - Induced pulmonary dysfunction in lung transplantation

Science Translational Medicine

Volumn 6, Issue 252, 2014, Pages

  Weber, Daniel J ^a   Gracon, Adam S A ^a   Ripsch, Matthew S ^a   Fisher, Amanda J ^a   Cheon, Bo M ^a   Pandya, Pankita H ^a   Vittal, Ragini ^a   Capitano, Maegan L ^a   Kim, Youngsook ^a   Allette, Yohance M ^a   Riley, Amanda A ^a   McCarthy, Brian P ^a   Territo, Paul R ^a   Hutchins, Gary D ^a   Broxmeyer, Hal E ^a   Sandusky, George E ^a   White, Fletcher A ^a   Wilkes, David S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; NEUTRALIZING ANTIBODY; PEPTIDE; TOLL LIKE RECEPTOR 4;

ACUTE LUNG INJURY; ADULT; AIRWAY RESISTANCE; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DONOR; FEMALE; HUMAN; HYPOXIA; LUNG COMPLIANCE; LUNG DISEASE; LUNG TRANSPLANTATION; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; PAO2/FIO2 RATIO; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PULMONARY NEUTROPHILIA; RESPIRATORY TRACT PARAMETERS; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; WILD TYPE; ANIMAL; BRAIN INJURY; C57BL MOUSE; COMPLICATION; DEFICIENCY; DRUG EFFECTS; EPITHELIUM CELL; HEART OUTPUT; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE LUNG INJURY; ADULT; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANTIBODIES, NEUTRALIZING; BRAIN INJURIES; CARDIAC OUTPUT; EPITHELIAL CELLS; FEMALE; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-10; LUNG; LUNG TRANSPLANTATION; MALE; MICE, INBRED C57BL; NF-KAPPA B; PEPTIDES; RECEPTORS, IMMUNOLOGIC; TISSUE DONORS; TOLL-LIKE RECEPTOR 4;

EID: 84907284550     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaw2634     Document Type: Erratum

References (63)

1. G. J. Bittle, P. G. Sanchez, Z. N. Kon, A. Claire Watkins, K. Rajagopal, R. N. Pierson III, J. S. Gammie, B. P. Griffith, The use of lung donors older than 55 years: A review of the United Network of Organ Sharing database. J. Heart Lung Transplant. 32, 760-768 (2013).
2. M. Cypel, S. Keshavjee, Strategies for safe donor expansion: Donor management, donations after cardiac death, ex-vivo lung perfusion. Curr. Opin. Organ Transplant. 18, 513-517 (2013).
3. D. L. Davison, M. Terek, L. S. Chawla, Neurogenic pulmonary edema. Crit. Care 16, 212 (2012).
4. F. Rincon, S. Ghosh, S. Dey, M. Maltenfort, M. Vibbert, J. Urtecho, W. McBride, M. Moussouttas, R. Bell, J. K. Ratliff, J. Jallo, Impact of acute lung injury and acute respiratory distress syndrome after traumatic brain injury in the United States. Neurosurgery 71, 795-803 (2012).
5. H. Yang, D. J. Antoine, U. Andersson, K. J. Tracey, The many faces of HMGB1: Molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J. Leukoc. Biol. 93, 865-873 (2013).
6. M. Maroso, S. Balosso, T. Ravizza, J. Liu, E. Aronica, A. M. Iyer, C. Rossetti, M. Molteni, M. Casalgrandi, A. A. Manfredi, M. E. Bianchi, A. Vezzani, Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16, 413-419 (2010).
7. P. Feldman, M. R. Due, M. S. Ripsch, R. Khanna, F. A. White, The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. J. Neuroinflammation 9, 180 (2012).
8. U. Andersson, K. J. Tracey, HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139-162 (2011).
9. S. T. Buckley, C. Ehrhardt, The receptor for advanced glycation end products (RAGE) and the lung. J. Biomed. Biotechnol. 2010, 917108 (2010).
10. C. Bopp, A. Bierhaus, S. Hofer, A. Bouchon, P. P. Nawroth, E. Martin, M. A. Weigand, Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 12, 201 (2008).
11. A. Bierhaus, P. M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D. M. Stern, P. P. Nawroth, Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83, 876-886 (2005).
12. G. P. Sims, D. C. Rowe, S. T. Rietdijk, R. Herbst, A. J. Coyle, HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28, 367-388 (2010).
13. A. Rouhiainen, J. Kuja-Panula, S. Tumova, H. Rauvala, RAGE-mediated cell signaling. Methods Mol. Biol. 963, 239-263 (2013).
14. V. Iori, M.Maroso,M. Rizzi, A. M. Iyer, R. Vertemara,M. Carli, A. Agresti, A. Antonelli,M. E. Bianchi, E. Aronica, T. Ravizza, A. Vezzani, Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol. Dis. 58, 102-114 (2013).
15. C. Fiuza, M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger, J. H. Shelhamer, A. F. Suffredini, Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101, 2652-2660 (2003).
16. C. J. Treutiger, G. E. Mullins, A. S. Johansson, A. Rouhiainen, H. M. Rauvala, H. Erlandsson-Harris, U. Andersson, H. Yang, K. J. Tracey, J. Andersson, J. E. Palmblad, High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254, 375-385 (2003).
17. A. K. Sharma, D. J. LaPar, M. L. Stone, Y. Zhao, I. L. Kron, V. E. Laubach, Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury. Am. J. Transplant. 13, 2255-2267 (2013).
18. S. Qin, H. Wang, R. Yuan, H. Li, M. Ochani, K. Ochani, M. Rosas-Ballina, C. J. Czura, J. M. Huston, E. Miller, X. Lin, B. Sherry, A. Kumar, G. Larosa, W. Newman, K. J. Tracey, H. Yang, Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203, 1637-1642 (2006).
19. G. Matute-Bello, G. Downey, B. B. Moore, S. D. Groshong, M. A. Matthay, A. S. Slutsky, W. M. Kuebler; Acute Lung Injury in Animals Study Group, An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725-738 (2011).
20. T. Kawai, S. Akira, The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
21. V. Y. Toshchakov, H. Szmacinski, L. A. Couture, J. R. Lakowicz, S. N. Vogel, Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: Identification of the TLR4 Toll/IL-1 receptor domain dimerization interface. J. Immunol. 186, 4819-4827 (2011).
22. M. Sakaguchi, H. Murata, K. Yamamoto, T. Ono, Y. Sakaguchi, A. Motoyama, T. Hibino, K. Kataoka, N. H. Huh, TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLOS One 6, e23132 (2011).
23. E. W. Putranto, H. Murata, K. Yamamoto, K. Kataoka, H. Yamada, J. Futami, M. Sakaguchi, N. H. Huh, Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization. Int. J. Mol. Med. 32, 938-944 (2013).
24. V. U. Toshchakov, S. Basu, M. J. Fenton, S. N. Vogel, Differential involvement of BB loops of Toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J. Immunol. 175, 494-500 (2005).
25. A. Bierhaus, K. M. Haslbeck, P. M. Humpert, B. Liliensiek, T. Dehmer, M. Morcos, A. A. Sayed, M. Andrassy, S. Schiekofer, J. G. Schneider, J. B. Schulz, D. Heuss, B. Neundörfer, S. Dierl, J. Huber, H. Tritschler, A. M. Schmidt, M. Schwaninger, H. U. Haering, E. Schleicher, M. Kasper, D. M. Stern, B. Arnold, P. P. Nawroth, Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J. Clin. Invest. 114, 1741-1751 (2004).
26. H. C. Wang, O. Bloom, M. H. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. T. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama, K. J. Tracey, HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251 (1999).
27. U. Andersson, H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, K. J. Tracey, High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570 (2000).
28. A. Rouhiainen, J. Kuja-Panula, E. Wilkman, J. Pakkanen, J. Stenfors, R. K. Tuominen, M. Lepäntalo, O. Carpén, J. Parkkinen, H. Rauvala, Regulation of monocyte migration by amphoterin (HMGB1). Blood 104, 1174-1182 (2004).
29. D. Yang, Q. Chen, H. Yang, K. J. Tracey, M. Bustin, J. J. Oppenheim, High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81, 59-66 (2007).
30. R. K. Wolfson, E. T. Chiang, J. G. N. Garcia, HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc. Res. 81, 189-197 (2011).
31. M. A. van Zoelen, H. Yang, S. Florquin, J. C.Meijers, S. Akira, B. Arnold, P. P. Nawroth, A. Bierhaus, K. J. Tracey, T. van der Poll, Role of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31, 280-284 (2009).
32. H. S. Hreggvidsdottir, T. Ostberg, H. Wähämaa, H. Schierbeck, A. C. Aveberger, L. Klevenvall, K. Palmblad, L. Ottosson, U. Andersson, H. E. Harris, The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86, 655-662 (2009).
33. H. S. Hreggvidsdóttir, A. M. Lundberg, A. C. Aveberger, L. Klevenvall, U. Andersson, H. E. Harris, High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol. Med. 18, 224-230 (2012).
34. C. M. Sirois, T. Jin, A. L. Miller, D. Bertheloot, H. Nakamura, G. L. Horvath, A. Mian, J. Jiang, J. Schrum, L. Bossaller, K. Pelka, N. Garbi, Y. Brewah, J. Tian, C. Chang, P. S. Chowdhury, G. P. Sims, R. Kolbeck, A. J. Coyle, A. A. Humbles, T. S. Xiao, E. Latz, RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. J. Exp. Med. 210, 2447-2463 (2013).
35. J. Qiu, M. Nishimura, Y. Wang, J. R. Sims, S. Qiu, S. I. Savitz, S. Salomone, M. A. Moskowitz, Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 28, 927-938 (2008).
36. Y.Okuma, K. Liu, H.Wake, J. Zhang, T. Maruo, I. Date, T. Yoshino, A. Ohtsuka, N. Otani, S. Tomura, K. Shima, Y. Yamamoto, H. Yamamoto, H. K. Takahashi, S. Mori, M. Nishibori, Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann. Neurol. 72, 373-384 (2012).
37. L. A. J. O'Neill, The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226, 10-18 (2008).
38. K. A. Fitzgerald, Z. J. Chen, Sorting out Toll signals. Cell 125, 834-836 (2006).
39. C. A. Dinarello, Proinflammatory cytokines. Chest 118, 503-508 (2000).
40. L. O'Neill, The Toll/interleukin-1 receptor domain: A molecular switch for inflammation and host defence. Biochem. Soc. Trans. 28, 557-563 (2000).
41. E. Venereau, M. Schiraldi, M. Uguccioni, M. E. Bianchi, HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol. Immunol. 55, 76-82 (2013).
42. H. Yang, P. Lundbäck, L. Ottosson, H. Erlandsson-Harris, E. Venereau, M. E. Bianchi, Y. Al-Abed, U. Andersson, K. J. Tracey, D. J. Antoine, Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 18, 250-259 (2012).
43. L. Zandarashvili, D. Sahu, K. Lee, Y. S. Lee, P. Singh, K. Rajarathnam, J. Iwahara, Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy. J. Biol. Chem. 288, 11621-11627 (2013).
44. J. R. van Beijnum, W. A. Buurman, A. W. Griffioen, Convergence and amplification of tolllike receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11, 91-99 (2008).
45. X. Wu, Y. Mi, H. Yang, A. Hu, Q. Zhang, C. Shang, The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway. Mol. Cell. Biochem. 380, 249-257 (2013).
46. Z. G. Luan, H. Zhang, P. T. Yang, X. C. Ma, C. Zhang, R. X. Guo, HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells. Immunobiology 215, 956-962 (2010).
47. Y. H. Qin, S. M. Dai, G. S. Tang, J. Zhang, D. Ren, Z. W. Wang, Q. Shen, HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J. Immunol. 183, 6244-6250 (2009).
48. H. J. Huttunen, C. Fages, H. Rauvala, Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924 (1999).
49. K. G. Raman, P. L. Sappington, R. Yang, R. M. Levy, J. M. Prince, S. Liu, S. K. Watkins, A. M. Schmidt, T. R. Billiar, M. P. Fink, The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G556-G565 (2006).
50. M. A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M. F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, A. M. Schmidt, RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (1999).
51. M. Cypel, M. Liu, M. Rubacha, J. C. Yeung, S. Hirayama, M. Anraku, M. Sato, J. Medin, B. L. Davidson, M. de Perrot, T. K. Waddell, A. S. Slutsky, S. Keshavjee, Functional repair of human donor lungs by IL-10 gene therapy. Sci. Transl. Med. 1, 4ra9 (2009).
52. J. D. Christie, C. V. Shah, S. M. Kawut, N. Mangalmurti, D. J. Lederer, J. R. Sonett, V. N. Ahya, S. M. Palmer, K. Wille, V. Lama, P. D. Shah, A. Shah, A. Weinacker, C. S. Deutschman, B. A. Kohl, E. Demissie, S. Bellamy, L. B. Ware; Lung Transplant Outcomes Group, Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am. J. Respir. Crit. Care Med. 180, 1010-1015 (2009).
53. 2AR and mGluR5 on BMDCs aggravates traumatic brain injury-induced acute lung injury. J. Exp. Med. 210, 839-851 (2013).
54. B. Liliensiek, M. A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H. J. Gröne, F. C. Kurschus, A. M. Schmidt, S. D. Yan, E. Martin, E. Schleicher, D. M. Stern, G. Gü Hämmerling, P. P. Nawroth, B. Arnold, Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113, 1641-1650 (2004).
55. J. M. Brittain, L. Chen, S. M. Wilson, T. Brustovetsky, X. Gao, N. M. Ashpole, A. I. Molosh, H. You, A. Hudmon, A. Shekhar, F. A. White, G. W. Zamponi, N. Brustovetsky, J. Chen, R. Khanna, Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J. Biol. Chem. 286, 37778-37792 (2011).
56. J. C. Zampell, A. Yan, T. Avraham, V. Andrade, S. Malliaris, S. Aschen, S. G. Rockson, B. J. Mehrara, Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am. J. Physiol. Cell Physiol. 300, C1107-C1121 (2011).
57. S. Bhangoo, D. Ren, R. J. Miller, K. J. Henry, J. Lineswala, C. Hamdouchi, B. Li, P. E. Monahan, D. M. Chan, M. S. Ripsch, F. A. White, Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: A mechanism for the development of chronic sensitization of peripheral nociceptors. Mol. Pain 3, 38 (2007).
58. L. Fan, H. L. Benson, R. Vittal, E. A. Mickler, R. Presson, A. J. Fisher, O. W. Cummings, K. M. Heidler, M. R. Keller, W. J. Burlingham, D. S. Wilkes, Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am. J. Transplant. 11, 911-922 (2011).
59. N. C. Rouze, M. Schmand, S. Siegel, G. D. Hutchins, Design of a small animal PET imaging system with 1 microliter volume resolution. IEEE Trans. Nucl. Sci. 51, 757-763 (2004).
60. V. C. Soon, M. A. Miller, G. D. Hutchins, A non-iterative method for emission tomographic image reconstruction with resolution recovery. Nucl. Sci. Symp. Conf. Rec. 3468-3473 (2007).
61. M. C. Kreissl, H. M. Wu, D. B. Stout, W. Ladno, T. H. Schindler, X. L. Zhang, J. O. Prior, M. L. Prins, A. F. Chatziioannou, S. C. Huang, H. R. Schelbert, Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET. J. Nucl. Med. 47, 974-980 (2006).
62. C. Studholme, D. J. Hawkes, D. L. Hill, Normalized entropy measure for multimodality image alignment. Proc. SPIE Med. Imaging 3338, 132-143 (1998).
63. M. Profant, K. Vyska, U. Eckhardt, The Stewart-Hamilton equations and the indicator dilution method. SIAM J. Appl. Math. 34, 666-675 (1978).